Cargando…
Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
There is a large, global unmet need for the development of countermeasures to combat intracellular pathogens. The development of novel antimicrobials is expensive and slow and typically focuses on selective inhibition of proteins encoded by a single pathogen, thereby providing a narrow spectrum of c...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2018
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807128/ https://www.ncbi.nlm.nih.gov/pubmed/29298032 http://dx.doi.org/10.1021/acsinfecdis.7b00268 |